Browsing by Author Elisaf, M. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 87 to 106 of 573 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Chronic hyponatremia due to reset osmostat in a patient with colon cancerElisaf, M. S.; Konstantinides, A.; Siamopoulos, K. C.24-Nov-2015-
Chronic renal dysfunction in hemorrhagic fever with renal syndrome patientsElisaf, M. S.; Korakis, H.; Siamopoulos, K. C.24-Nov-2015-
Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinicLiamis, G.; Tsimihodimos, V.; Doumas, M.; Spyrou, A.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particlesGazi, I. F.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Clinical use of Nebivolol in the treatment of chronic heart failureLiberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Clopidogrel vs. aspirin treatment on admission improves 5-year survival after a first-ever acute ischemic stroke. data from the Athens Stroke Outcome ProjectMilionis, H. J.; Gerotziafas, G.; Kostapanos, M. S.; Vemmou, A.; Zis, P.; Spengos, K.; Elisaf, M. S.; Vemmos, K. N.24-Nov-2015-
Co-trimoxazole-induced hypouricemiaLiberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implicationsTsimihodimos, V.; Kakaidi, V.; Elisaf, M. S.24-Nov-2015-
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemiaFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Combination drug treatment in patients with non-alcoholic fatty liver diseaseFilippatos, T. D.; Elisaf, M. S.24-Nov-2015-
Combination of fenofibrate with non-statin drug regimensAgouridis, A. P.; Filippatos, T. D.; Derdemezis, C. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot studyRizos, E.; Bairaktari, E.; Kostoula, A.; Hasiotis, G.; Achimastos, A.; Ganotakis, E.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolismAgouridis, A. P.; Filippatos, T. D.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidenceTsouli, S. G.; Liberopoulos, E. N.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemiaLiamis, G.; Kakafika, A.; Bairaktari, E.; Miltiadous, G.; Tsimihodimos, V.; Goudevenos, J.; Achimastos, A.; Elisaf, M. S.24-Nov-2015-
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase ARizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemiaMilionis, H. J.; Papakostas, J.; Kakafika, A.; Chasiotis, G.; Seferiadis, K.; Elisaf, M. S.24-Nov-2015-
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and goutLiberopoulos, E.; Christides, D.; Elisaf, M. S.24-Nov-2015-
Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L)Liberopoulos, E. N.; Florentin, M.; Kei, A.; Mountzouri, E.; Agouridis, A.; Elisaf, M. S.24-Nov-2015-